High Accuracy Oral Drug Abuse Test Kit Midstream Gold Colloidal Method

Oral Drug Abuse Test kit ,Oral Drug Test midstream, High Accuracy, Easily & Quick operation, Gold colloidal method

This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) and gas chromatography/tandem mass spectrometry (GC/MS/MS) are the preferred confirmatory methods. Professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.


Summary


Amphetamine (AMP)

Amphetamine is a sympathomimetic amine with therapeutic indications. The drug is often self-administered by nasal inhalation or oral ingestion. Depending on the route of administration, amphetamine can be detected in oral fluid as early as 5 -10 minutes following use1. Amphetamine can be detected in oral fluids for up to 72 hours after use1.

The amphetamine assay contained within the Multi-Drug Rapid Test Midstream yields a positive result when the amphetamine concentration in oral fluid exceeds 50ng/ml.

Methamphetamine (MET)

Methamphetamine is a potent stimulant chemically related to amphetamine but with greater CNS stimulation properties. The drug is often self-administered by nasal inhalation, smoking or oral ingestion. Depending on the route of administration, methamphetamine can be detected in oral fluid as early as 5-10 minutes following use1. Methamphetamine can be detected in oral fluids for up to 72 hours after use1.

The Methamphetamine assay contained within the Multi-Drug Rapid Test Midstream yields a positive result when the methamphetamine concentration in oral fluid exceeds 50ng/ml.

Cocaine (COC)

Cocaine is a potent central nervous system (CNS) stimulant and a local anesthetic derived from the coca plant (erythroxylum coca). The drug is often self-administered by nasal inhalation, intravenous injection and free-base smoking. Depending on the route of administration, cocaine and metabolites benzoylecgonine and ecgonine methyl ester can be detected in oral fluid as early as 5-10 minutes following use1. Cocaine and benzoylecgonine can be detected in oral fluids for up to 24 hours after use1.

The cocaine assay contained within the Multi-Drug Rapid Test Midstream for cocaine and opiates yields a positive result when the cocaine metabolite in oral fluid exceeds 20ng/ml.

Opiates (OPI/MOP)

The drug class opiates refers to any drug that is derived from the opium poppy, including naturally occurring compounds such as morphine and codeine and semi-synthetic drugs such as heroin. Opiates act to control pain by depressing the central nervous system. The drugs demonstrate addictive properties when used for sustained periods of time; symptoms of withdrawal may include sweating, shaking, nausea and irritability. Opiates can be taken orally or by injection routes including intravenous, intramuscular and subcutaneous; illegal users may also take the intravenously or by nasal inhalation. Using an immunoassay cutoff level of 40 ng/ml, codeine can be detected in the oral fluid within 1 hour following a single oral dose and can remain detectable for 7-21 hours after the dose2. Heroin metabolite 6-monoacetylmorphine (6-MAM) is found more prevalently in excreted unmetabolized, and is also the major metabolic product of codeine and heroin.
The opiates assay contained within the Multi-Drug Rapid Test Midstream yields a positive result when the opiates concentration in oral fluid exceeds 40 ng/ml.

Marijuana (THC)

11-nor-9-tetrahydrocannabinol-9-carboxylic acid (9-THC-COOH), the metabolite of THC ( 9-tetrahydrocannabinol), is detectable in saliva shortly after use. The detection of the drug is thought to be primarily due to the direct exposure of the drug to the mouth (oral and smoking administrations) and the subsequent sequestering of the drug in the buccal cavity3. Historical studies have shown a window of detection for THC in saliva of up to 14 hours after drug use3.

The THC assay contained within the Multi-Drug Rapid Test Midstream yields a positive result when the 9-tetrahydrocannabinol concentration in oral fluid exceeds 50ng/ml.

Allow the test, urine specimen, and/or controls to reach room temperature
(15-30ºC) prior to testing.

1. Bring the pouch to room temperature before opening it. Remove the test from the sealed pouch and use it within one hour.
2. Take off the Midstream cap and insert the absorbent wick to the mouth .put it under the tongue to collect Saliva until the control line appears and then take out the midstream.
3. Place the test Midstream on a clean and level surface. See illustration below.
4. Read results at 10 minutes. Do not read results after 1 hour
5. Read Alcohol strip result at three to Five (3-5) minutes. Compare the color of the reaction pad with the chart on foil to determine the relative saliva alcohol level.




INTERPRETATION OF RESULTS

NEGATIVE:* Two lines appear. One colored line should be in the control region (C), and another apparent colored line adjacent should be in the test region (Drug/T). This negative result indicates that the drug concentration is below the detectable level. *NOTE: The shade of color in the test line region (Drug/T) will vary, but it should be considered negative whenever there is even a faint line.

POSITIVE: One colored line appears in the control region (C). No line appears in the test region (Drug/T). This positive result indicates that the drug concentration is above the detectable level. INVALID: Control line fails to appear. Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for control line failure. Review the procedure and repeat the test using a new test panel. If the problem persists, discontinue using the lot immediately and contact the manufacturer.

QUALITY CONTROL

A procedural control is included in the test. A line appearing in the control region
(C) is considered an internal procedural control. It confirms sufficient specimen volume, adequate membrane wicking and correct procedural technique.
Control standards are not supplied with this kit. However, it is recommended that positive and negative controls be tested as good laboratory practice to confirm the test procedure and to verify proper test performance.

Established in 2009, Orient New Life Medical Co., Ltd., is specialized in high-tech biological diagnostic test development, research and production, as well as high-tech medical device development, research and production. New Life has built up two production base, which produce biological diagnostic test and endoscopic medical device respectively. Our products ranged in the following specialties: drug of abuse tests, fertility tests, infectious diseases tests, sexual transmitted diseases tests, tumor markers tests, cardiac markers tests, veterinary tests, and surgical stapler series.

NEW LIFE have 3 wholly-owned and joint stock subsidiary companies, including Orient New Life Medical Co., Ltd., Orient Gene Biotech Co., Ltd., Qianjing Medical Equipment Co., Ltd.

Company's core technical team with more than 35 employees，3 doctors and 25 masters. They have many years of famous universities in the United States and pharmaceutical companies engaged in the project research and development, production and marketing, business management experience.Company owns hundreds of grade purification workshop and all level of quality checkout room, equipped with various production and testing equipment.